Development of Extended-Release Solid Dispersions of Nonsteroidal Antiinflammatory Drugs with Aqueous Polymeric Dispersions: Optimization of Drug Release via a Curve-Fitting Technique

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Pharmaceutical Research

• Publication date

  1992-02-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1023/A:1018933306162PMID 1553343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sustained release solid dispersions of indomethacin with Eudragit RS and RL

  1989cited by this paper
• Influence of Formulation and Other Factors on the Release of Chlorpheniramine Mateate from Polymer Coated Beads

  1987cited by this paper
• Bioavailability and stability of nifedipine-enteric coating agent solid dispersion.

  1985cited by this paper
• [Solid dispersion obtained from nifedipine and enteric coating agents. I. Dissolution behavior].

  1984cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper
• MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

  1963cited by this paper
• Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man.

  1961cited by this paper

• Enhancement of Dissolution Rate of Piroxicam Using Solid Dispersions With PEG-6000 and Eudragit RL-100

  2016cites this paper
• Influence of process parameters on the formation of controlled release lipospheres of ketoprofen and their characterization

  2016cites this paper
• Establishment of criteria for the selection and adaptation of objectives and indicators in ISO9001:2008 quality system in a university pharmaceutical pilot plant

  2015cites this paper
• Interpolyelectrolyte Complexes of Eudragit® EPO with Hypromellose Acetate Succinate and Eudragit® EPO with Hypromellose Phthalate as Potential Carriers for Oral Controlled Drug Delivery

  2015cites this paper
• Influence of polymethacrylates and compritol on release profile of a highly water soluble drug metformin hydrochloride

  2015cites this paper
• Influence of polymethacrylates and compritol on release profile of a highly water soluble drug metformin hydrochloride

  2015cites this paper
• Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies

  2012cites this paper
• Design and Optimization of Novel Sugar Alcohol Based Extended Release Tablets Prepared by Melt Dispersion Technique

  2012cites this paper
• Study of analgesic effect of naproxen solid dispersions in crosspovidone and Elaeagnus Angustifolia fruit powder by using formalin test

  2009cites this paper
• Formulation of Sustained-Release Dosage Form of Verapamil Hydrochloride by Solid Dispersion Technique Using Eudragit RLPO or Kollidon®SR

  2009cites this paper
• Optimizing drug delivery systems using systematic "design of experiments." Part II: retrospect and prospects.

  2005cites this paper
• Micelles in anticancer drug delivery

  2004cites this paper
• Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100.

  2001cites this paper
• Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipients.

  1998cites this paper